Taiyen Biotech Co (TPE:1737) Retained Earnings: NT$914 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1737 Taiyen Biotech Co Ltd TPE:1737
81 GF Score
Price NT$31.90
GF Value NT$31.80
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Taiyen Biotech Co Retained Earnings?

Taiyen Biotech Co TPE:1737 81 Retained Earnings is NT$914 Mil as of Mar. 2026. GuruFocus rates TPE:1737 with a GF Score™ of 81/100 and a GF Value™ of NT$31.80 (Fairly Valued). The stock has 1 warning sign investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Taiyen Biotech Co's retained earnings for the quarter that ended in Mar. 2026 was NT$914 Mil.

Taiyen Biotech Co's quarterly retained earnings increased from Sep. 2025 (NT$653 Mil) to Dec. 2025 (NT$820 Mil) and increased from Dec. 2025 (NT$820 Mil) to Mar. 2026 (NT$914 Mil).

Taiyen Biotech Co's annual retained earnings increased from Dec. 2023 (NT$555 Mil) to Dec. 2024 (NT$700 Mil) and increased from Dec. 2024 (NT$700 Mil) to Dec. 2025 (NT$820 Mil).


Taiyen Biotech Co  (TPE:1737) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Taiyen Biotech Co Retained Earnings Historical Data

* Premium members only.

The historical data trend for Taiyen Biotech Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiyen Biotech Co Retained Earnings Chart

Taiyen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 510.28 631.04 555.31 700.32 819.54

Taiyen Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 797.61 580.62 652.98 819.54 914.00
TPE:1737
81GF Score
Taiyen Biotech Co Ltd TPE:1737
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiyen Biotech Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of NT$914 Mil mean?
Taiyen Biotech Co (TPE:1737) has a Retained Earnings of NT$914 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Taiyen Biotech Co and its competitors.
Is Taiyen Biotech Co's Retained Earnings too high?
Taiyen Biotech Co's current Retained Earnings is NT$914 Mil. Overall, Taiyen Biotech Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Retained Earnings compare to PG and CL?
Taiyen Biotech Co's Retained Earnings of NT$914 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Consumer Packaged Goods company?
A good Retained Earnings depends on the Consumer Packaged Goods industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Taiyen Biotech Co and its competitors. Taiyen Biotech Co's current Retained Earnings is NT$914 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$31.80, compared to a current price of NT$31.90 — trading 0.3% above its estimated fair value. The current Retained Earnings is NT$914 Mil. Taiyen Biotech Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Retained Earnings is NT$914 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?

Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be overvalued. The current stock price of NT$31.90 is trading 0.3% above its estimated GF Value™ of NT$31.80. GuruFocus considers Taiyen Biotech Co to be Fairly Valued.

Key valuation signals for TPE:1737:

  • Retained Earnings: NT$914 Mil
  • GF Value™: NT$31.80 vs. price of NT$31.90 (0.3% above fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Taiyen Biotech Co Business Description

Address No. 297, Section 1, Chien-Kang Road, South District, Tainan, TWN
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
81GF Score

Get the complete analysis for TPE:1737

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.90
Price
NT$31.80
GF Value